ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
dontfollowme
|
77 |
18K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
13
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Part 1 Remplir US Market Authorisation Successfully Complete
|
|
dontfollowme
|
35 |
9.7K |
4 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
35
|
9.7K
|
4
|
|
ASX - By Stock
|
CPV |
Re:
Ann: CPV secures $4 million Placement and launches $2 million SPP
|
|
dontfollowme
|
36 |
12K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
36
|
12K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Appendix 4D and Half Year Report
|
|
dontfollowme
|
12 |
3.1K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
12
|
3.1K
|
0
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Application for quotation of securities - ME1
|
|
dontfollowme
|
7 |
1.9K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
7
|
1.9K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Imbio secures research agreement with US Dept of Vet Affairs
|
|
dontfollowme
|
26 |
7.0K |
12 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
26
|
7.0K
|
12
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dontfollowme
|
15 |
4.2K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
15
|
4.2K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: FY24 Guidance Update - Subscription Transition Accelerates
|
|
dontfollowme
|
20 |
6.0K |
0 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
20
|
6.0K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical webinar with Dr David Shulkin
|
|
dontfollowme
|
41 |
14K |
1 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
41
|
14K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: MDC HY23 Interim Report
|
|
dontfollowme
|
8 |
1.8K |
3 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
8
|
1.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Joseph Swedish
|
|
dontfollowme
|
31 |
11K |
5 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
31
|
11K
|
5
|
|
ASX - By Stock
|
BFG |
Re:
News: BFG Bell Financial Group Says HY Profit After Tax A$11.1 Million
|
|
dontfollowme
|
20 |
9.4K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
20
|
9.4K
|
0
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Identitii extends runway via sale of Payble shares
|
|
dontfollowme
|
140 |
30K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
140
|
30K
|
2
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Identitii extends runway via sale of Payble shares
|
|
dontfollowme
|
140 |
30K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
140
|
30K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Commercialisation Milestone
|
|
dontfollowme
|
341 |
107K |
7 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
341
|
107K
|
7
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Corporate Update
|
|
dontfollowme
|
20 |
4.9K |
10 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
20
|
4.9K
|
10
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Corporate Update
|
|
dontfollowme
|
20 |
4.9K |
11 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
20
|
4.9K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
dontfollowme
|
120 |
44K |
3 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
44K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Commercialisation Milestone
|
|
dontfollowme
|
341 |
107K |
5 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
341
|
107K
|
5
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Meeting Results
|
|
dontfollowme
|
8 |
2.0K |
1 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
8
|
2.0K
|
1
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: HSBC Australia contract will expire on 31 December 2023
|
|
dontfollowme
|
6 |
1.8K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
6
|
1.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
dontfollowme
|
716 |
198K |
2 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
198K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Notice of Extraordinary General Meeting / Proxy Form
|
|
dontfollowme
|
34 |
8.2K |
3 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
34
|
8.2K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
dontfollowme
|
153 |
47K |
7 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
153
|
47K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical receives U.S. FDA clearance for CT LVAS
|
|
dontfollowme
|
38 |
16K |
8 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
38
|
16K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Presentation to Bell Potter Healthcare Conference
|
|
dontfollowme
|
30 |
14K |
7 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
30
|
14K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. CMS Approves Reimbursement for 4DMedical
|
|
dontfollowme
|
150 |
66K |
5 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
150
|
66K
|
5
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
dontfollowme
|
38K |
17M |
1 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
dontfollowme
|
38K |
17M |
1 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
38K
|
17M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
dontfollowme
|
231 |
64K |
2 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
231
|
64K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
dontfollowme
|
1.6K |
465K |
2 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
1.6K
|
465K
|
2
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dontfollowme
|
5 |
1.4K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
5
|
1.4K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Medlab Update to Shareholders
|
|
dontfollowme
|
3 |
1.9K |
5 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
3
|
1.9K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib
|
|
dontfollowme
|
6 |
2.1K |
4 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
6
|
2.1K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dontfollowme
|
184 |
46K |
7 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
184
|
46K
|
7
|
|
ASX - By Stock
|
CXO |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
dontfollowme
|
159 |
64K |
2 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
159
|
64K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: $3.77 million R&D Tax Incentive received
|
|
dontfollowme
|
21 |
7.6K |
7 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
21
|
7.6K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 4E & Annual Report
|
|
dontfollowme
|
30 |
12K |
3 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
30
|
12K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Share Purchase Plan (SPP) Raises $3.26 Million
|
|
dontfollowme
|
6 |
2.0K |
3 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
6
|
2.0K
|
3
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Removal of Minimum Raise Amount from Entitlement Offer
|
|
dontfollowme
|
56 |
14K |
10 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
56
|
14K
|
10
|
|
ASX - By Stock
|
CXO Lithium |
Re:
How to screw over short-sellers
|
|
dontfollowme
|
846 |
334K |
3 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
846
|
334K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
dontfollowme
|
1.3K |
544K |
14 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
14
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Virtual Investor Q&A
|
|
dontfollowme
|
21 |
5.5K |
2 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
21
|
5.5K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Quarterly Cash Flows and Activities Statement
|
|
dontfollowme
|
18 |
5.0K |
3 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
18
|
5.0K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Institutional Placement and proposed Share Purchase Plan SPP
|
|
dontfollowme
|
71 |
18K |
1 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
71
|
18K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race global agreement with City of Hope to access FTO IP
|
|
dontfollowme
|
268 |
80K |
13 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
268
|
80K
|
13
|
|
ASX - By Stock
|
BFG |
Re:
Ann: Finalisation of AUSTRAC external audit
|
|
dontfollowme
|
5 |
1.9K |
0 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Medlab Update to Shareholders
|
|
dontfollowme
|
11 |
5.9K |
3 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
11
|
5.9K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical completes oversubscribed $25m SPP
|
|
dontfollowme
|
13 |
6.1K |
1 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
13
|
6.1K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Argus Successful Field Testing
|
|
dontfollowme
|
63 |
18K |
0 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
63
|
18K
|
0
|
|